Eagle Pharmaceuticals
EGRX
#9801
Rank
A$15.03 M
Marketcap
$1.16
Share price
-11.76%
Change (1 day)
-92.21%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Cash on Hand

Cash on Hand as of June 2023 : A$23.74 Million

According to Eagle Pharmaceuticals 's latest financial reports the company has A$23.74 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Eagle Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$81.29 M-39.65%
2021-12-31A$0.13 B0.41%
2020-12-31A$0.13 B-14.44%
2019-12-31A$0.15 B40.19%
2018-12-31A$0.11 B-23.85%
2017-12-31A$0.14 B100.42%
2016-12-31A$73.27 M-32.5%
2015-12-31A$0.10 B
2014-09-30A$49 M335.98%
2013-09-30A$11.24 M77.65%
2012-09-30A$6.32 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$31.39 B 132,093.57%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.64 B 27,897.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$21.68 B 91,211.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$5.13 B 21,516.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$13.93 B 58,588.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.44 B 22,815.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.51 B 52,615.90%๐Ÿ‡บ๐Ÿ‡ธ USA